Uncommon Glioneuronal Tumors: A Radiologic and Pathologic Synopsis

References

1. 1.↵
   1. Gatto L,
   2. Franceschi E,
   3. Nunno VD, et al

   . Glioneuronal tumors: clinicopathological findings and treatment options. Future Neurol 2020;15:FNL47 doi:10.2217/fnl-2020-0003

   CrossRef
2. 2.↵
   1. Shin JH,
   2. Lee HK,
   3. Khang SK, et al

   . Neuronal tumors of the central nervous system: radiologic findings and pathologic correlation. Radiographics 2002;22:1177–89 doi:10.1148/radiographics.22.5.g02se051177 pmid:12235346

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Osborn AG,
   2. Hedlund GL,
   3. Salzman KL

   . Osborn’s Brain: Imaging, Pathology, and Anatomy. 2nd ed. Elsevier; 2017
4. 4.↵
   1. Chougule M

   . Neuropathology of Brain Tumors with Radiologic Correlates. Springer-Verlag; 2020
5. 5.↵
   1. Abdel Razek AA,
   2. Elsebaie NA,
   3. Zamora C, et al

   . Imaging of neuronal and mixed glioneuronal tumors. J Comput Assist Tomogr 2020;44:356–69 doi:10.1097/RCT.0000000000001010 pmid:32217897

   CrossRefPubMed
6. 6.↵
   1. Louis DN,
   2. Wesseling P,
   3. Aldape K, et al

   . cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol 2020;30:844–56 doi:10.1111/bpa.12832 pmid:32307792

   CrossRefPubMed
7. 7.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab1063 pmid:4185076

   CrossRefPubMed
8. 8.↵
   1. Louis DN,
   2. Perry A,
   3. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
9. 9.↵
   1. Lucas JT Jr.
   2. Huang AJ,
   3. Mott RT, et al

   . Anaplastic ganglioglioma: a report of three cases and review of the literature. J Neurooncol 2015;123:171–77 doi:10.1007/s11060-015-1781-6 pmid:25862009

   CrossRefPubMed
10. 10.↵
    1. Baño AN,
    2. Fernández-Hernández CM,
    3. García CS, et al

    . Parietal anaplastic ganglioglioma in a 3-year-old girl. https://www.eurorad.org/case/14890. Accessed July 1, 2021
11. 11.↵
    1. Williams SR,
    2. Joos BW,
    3. Parker JC, et al

    . Papillary glioneuronal tumor: a case report and review of the literature. Ann Clin Lab Sci 2008;38:287–92 pmid:18715860

    Abstract/FREE Full Text
12. 12.↵
    1. Myung JK,
    2. Byeon SJ,
    3. Kim B, et al

    . Papillary glioneuronal tumors: a review of clinicopathologic and molecular genetic studies. Am J Surg Pathol 2011;35:1794–1805 doi:10.1097/PAS.0b013e31823456e6 pmid:22020040

    CrossRefPubMed
13. 13.↵
    1. Yadav N,
    2. Rao S,
    3. Saini J, et al

    . Papillary glioneuronal tumors: a radiopathologic correlation. Eur J Radiology 2017;97:44–52 doi:10.1016/j.ejrad.2017.10.004 pmid:29153366

    CrossRefPubMed
14. 14.↵
    1. Konya D,
    2. Peker S,
    3. Ozgen S, et al

    . Superficial siderosis due to papillary glioneuronal tumor. J Clin Neurosci 2006;13:950–52 doi:10.1016/j.jocn.2005.10.014 pmid:17049863

    CrossRefPubMed
15. 15.↵
    1. Bridge JA,
    2. Liu XQ,
    3. Sumegi J, et al

    . Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor. Brain Pathol 2013;23:121–28 doi:10.1111/j.1750-3639.2012.00612.x pmid:22725730

    CrossRefPubMed
16. 16.↵
    1. Vaquero J,
    2. Coca S

    . Atypical papillary glioneuronal tumor. J Neurooncol 2007;83:319–23 doi:10.1007/s11060-007-9333-3 pmid:17285229

    CrossRefPubMed
17. 17.↵
    1. Javahery RJ,
    2. Davidson L,
    3. Fangusaro J, et al

    . Aggressive variant of a papillary glioneuronal tumor: report of 2 cases. J Neurosurg Pediatr Pediatr 2009;3:46–52 doi:10.3171/2008.10.PEDS08242 pmid:19119904

    CrossRefPubMed
18. 18.↵
    1. Sievers P,
    2. Appay R,
    3. Schrimpf D, et al

    . Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1. Acta Neuropathol 2019;138:497–504 doi:10.1007/s00401-019-02038-4 pmid:31250151

    CrossRefPubMed
19. 19.↵
    1. Gao L,
    2. Han F,
    3. Jin Y, et al

    . Imaging features of rosette-forming glioneuronal tumours. Clin Radiology 2018;73:275–82 doi:10.1016/j.crad.2017.10.011 pmid:29146003

    CrossRefPubMed
20. 20.↵
    1. Ellezam B,
    2. Theeler BJ,
    3. Luthra R, et al

    . Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor. Acta Neuropathol 2012;123:285–87 doi:10.1007/s00401-011-0886-z pmid:21997360

    CrossRefPubMed
21. 21.↵
    1. Hsu C,
    2. Kwan G,
    3. Lau Q, et al

    . Rosette-forming glioneuronal tumour: imaging features, histopathological correlation and a comprehensive review of literature. Br J Neurosurg 2012;26:668–73 doi:10.3109/02688697.2012.655808 pmid:22512825

    CrossRefPubMed
22. 22.↵
    1. Medhi G,
    2. Prasad C,
    3. Saini J, et al

    . Imaging features of rosette-forming glioneuronal tumours (RGNTs): a series of seven cases. Eur Radiol 2016;26:262–70 doi:10.1007/s00330-015-3808-y pmid:26017735

    CrossRefPubMed
23. 23.↵
    1. Lucas CG,
    2. Villanueva-Meyer JE,
    3. Whipple N, et al

    . Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features. Brain Pathol 2020;30:479–94 doi:10.1111/bpa.12797 pmid:31609499

    CrossRefPubMed
24. 24.↵
    1. Solomon DA,
    2. Korshunov A,
    3. Sill M, et al

    . Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile. Acta Neuropathol 2018;136:339–43 doi:10.1007/s00401-018-1883-2 pmid:30006677

    CrossRefPubMed
25. 25.↵
    1. Narvaez ED,
    2. Inada BS,
    3. Almeida P, et al

    . Myxoid glioneuronal tumour–report of three cases of a new tumour in a typical location and review of literature. BJR Case Rep 2021;6:20200139 doi:10.1259/bjrcr.20200139 pmid:35047190

    CrossRefPubMed
26. 26.↵
    1. Lakhani DA,
    2. Mankad K,
    3. Chhabda S, et al

    . Diffuse leptomeningeal glioneuronal tumor of childhood. AJNR Am J Neuroradiol 2020;41:2155–59 doi:10.3174/ajnr.A6737 pmid:32912870

    Abstract/FREE Full Text
27. 27.↵
    1. Dodgshun AJ,
    2. SantaCruz N,
    3. Hwang J, et al

    . Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation. J Neurooncol 2016;128:293–302 doi:10.1007/s11060-016-2109-x pmid:26994902

    CrossRefPubMed
28. 28.↵
    1. Rodriguez FJ,
    2. Perry A,
    3. Rosenblum MK, et al

    . Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 2012;124:627–41 doi:10.1007/s00401-012-1037-x pmid:22941225

    CrossRefPubMed
29. 29.↵
    1. Xu H,
    2. Chen F,
    3. Zhu H, et al

    . Diffuse leptomeningeal glioneuronal tumor in a Chinese adult: a novel case report and review of literature. Acta Neurol Belg 2020;120:247–56 doi:10.1007/s13760-019-01262-9 pmid:31875302

    CrossRefPubMed
30. 30.↵
    1. Appay R,
    2. Pages M,
    3. Colin C, et al

    . Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases. Acta Neuropathol Commun 2020;8:95 doi:10.1186/s40478-020-00978-7 pmid:32605662

    CrossRefPubMed
31. 31.↵
    1. Rossi S,
    2. Rodriguez FJ,
    3. Mota RA, et al

    . Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child. Acta Neuropathol 2009;118:575–77 doi:10.1007/s00401-009-0565-5 pmid:19562354

    CrossRefPubMed
32. 32.↵
    1. Odia Y

    . Gangliocytomas and gangliogliomas: review of clinical, pathologic and genetic features. Clin Oncol 2016;1:1017
33. 33.↵
    1. Kim HS,
    2. Lee HK,
    3. Jeong AK, et al

    . Supratentorial gangliocytoma mimicking extra-axial tumor: a report of two cases. Korean J Radiol 2001;2:108–12 doi:10.3348/kjr.2001.2.2.108 pmid:11752979

    CrossRefPubMed
34. 34.↵
    1. Miyake Y,
    2. Mishima K,
    3. Suzuki T, et al

    . A case of suspicious gangliocytoma with heterogeneously distributed lesions in the thalamus and basal ganglia. NMC Case Rep J 2018;5:61–64 doi:10.2176/nmccrj.cr.2017-0169 pmid:29725570

    CrossRefPubMed
35. 35.↵
    1. Shinagare AB,
    2. Patil NK,
    3. Sorte SZ

    . Case 144: dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease). Radiology 2009;251:298–303 doi:10.1148/radiol.2511071390 pmid:19332858

    CrossRefPubMed
36. 36.↵
    1. Nunes RH,
    2. Hsu CC,
    3. da Rocha AJ, et al

    . Multinodular and vacuolating neuronal tumor of the cerebrum: a new “leave me alone” lesion with a characteristic imaging pattern. AJNR Am J Neuroradiol 2017;38:1899–1904 doi:10.3174/ajnr.A5281 pmid:28705817

    Abstract/FREE Full Text
37. 37.↵
    1. Agarwal A,
    2. Lakshmanan R,
    3. Devagnanam I, et al

    . Multinodular and vacuolating neuronal tumor of the cerebrum: does the name require review? AJNR Am J Neuroradiol 2019;40:E69–70 doi:10.3174/ajnr.A6284 pmid:31753835

    FREE Full Text
38. 38.↵
    1. Lecler A,
    2. Bailleux J,
    3. Carsin B, et al

    .; ENIGMA Investigation Group (EuropeaN Interdisciplinary Group for MVNT Analysis), Multinodular and vacuolating posterior fossa lesions of unknown significance. AJNR Am J Neuroradiol 2019;40:1689–94 doi:10.3174/ajnr.A6223 pmid:31558497

    Abstract/FREE Full Text
39. 39.↵
    1. Pekmezci M,
    2. Stevers M,
    3. Phillips JJ, et al

    . Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway. Acta Neuropathol 2018;135:485–88 doi:10.1007/s00401-018-1820-4 pmid:29428973

    CrossRefPubMed
40. 40.↵
    1. Gembruch O,
    2. Junker A,
    3. Mönninghoff C, et al

    . Liponeurocytoma: systematic review of a rare entity. World Neurosurg 2018;120:214–33 doi:10.1016/j.wneu.2018.09.001 pmid:30205225

    CrossRefPubMed
41. 41.↵
    1. Huse JT,
    2. Snuderl M,
    3. Jones DT, et al

    . Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 2017;133:417–29 doi:10.1007/s00401-016-1639-9 pmid:27812792

    CrossRefPubMed
42. 42.↵
    1. Sumdani H,
    2. Shahbuddin Z,
    3. Harper G, et al

    . Case report of rarely described polymorphous low-grade neuroepithelial tumor of the young and comparison with oligodendroglioma. World Neurosurg 2019;127:47–51 doi:10.1016/j.wneu.2019.03.181 pmid:30926558

    CrossRefPubMed
43. 43.↵
    1. Benson JC,
    2. Summerfield D,
    3. Carr C, et al

    . Polymorphous low-grade neuroepithelial tumor of the young as a partially calcified intra-axial mass in an adult. AJNR Am J Neuroradiol 2020;41:573–78 doi:10.3174/ajnr.A6500 pmid:32217553

    Abstract/FREE Full Text
44. 44.↵
    1. da Silva JF,
    2. de Souza Machado GH,
    3. Pedro MK, et al

    . Angiocentric glioma: literature review and first case in Brazil. Interdiscip Neurosurg 2019;18:100508 doi:10.1016/j.inat.2019.100508

    CrossRef